Advertisement

Topics

ADVANCED CELL & GENE THERAPY, LLC Company Profile

10:58 EDT 26th September 2017 | BioPortfolio

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, GMP/GTP manufacturing, and regulatory compliance, as well as comprehensive scientific and technical strategic analysis of business opportunities in cell, gene and tissue therapies.

Location

105 Highgrove Drive
Chapel Hill
North Carolina
27516-8376
United States of America

Contact

Phone: 919.969.1103
Fax: 919.969.9234
Email: celltherapy@ac-gt.com


News Articles [6651 Associated News Articles listed on BioPortfolio]

Oxford BioMedica enters gene and cell therapy manufacturing project

Gene and cell therapy group, Oxford BioMedica (OXB), has agreed to enter into a collaboration project as lead partner that will focus on gene and cell therapy manufacturing and will be co-funded by th...

FDA Approves First Gene Therapy

CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia The U.S. Food and […] The post FDA Approves First Gene Therapy appeared first on .

First approval of cell and gene therapy for knee osteoarthritis

What is claimed to be the world's first cell and gene therapy for degenerative arthritis has been approved…

Cell Medica Acquires Catapult Therapy for WT1 Cancer Immunotherapy Candidate

LONDON–(BUSINESS WIRE)–Cell Medica today announced the acquisition of Catapult Therapy TCR Limited, a subsidiary of Cell and Gene Therapy Catapult (CGT Catapult), and the initiation of a c...

Cell Medica Acquires Catapult Therapy for Lead WT1-TCR T Cell Therapy

Cell Medica is buying Catapult Therapy TCR and the firm's gene-modified WT1-TCR T cell therapy candidate. The treatment is currently in Phase I/II development for the potential treatment of acute ...

Cell Medica Acquires Catapult Therapy for Lead WT1-TCR T-Cell Therapy

Cell Medica is buying Catapult Therapy TCR and the firm's gene-modified WT1-TCR T cell therapy candidate. The treatment is currently in Phase I/II development for the potential treatment of acute ...

UK's CGT Catapult to Use TrakCel Supply Chain Management Platform

TrakCel said today it will incorporate its needle-to-needle supply chain management platform into the Cell and Gene Therapy (CGT) Catapult’s large-scale cell and gene therapy manufacturing center se...

U.K.'s CGT Catapult to Use TrakCel Supply Chain Management Platform

TrakCel said today it will incorporate its needle-to-needle supply chain management platform into the Cell and Gene Therapy (CGT) Catapult’s large-scale cell and gene therapy manufacturing center se...

Drugs and Medications [354 Associated Drugs and Medications listed on BioPortfolio]

Bio-corneum hc advanced scar supervision anti-itch [Advanced Bio-Technologies, Inc]

BIO-CORNEUM HC Advanced Scar Supervision Anti-Itch Gel

Shiseido advanced hydro-liquid compact (refill) [SHISEIDO CO., LTD.]

Shiseido Advanced Hydro-Liquid Compact Foundation

Alimta [Eli Lilly and Company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyophilized Powder, for ...

Vaseline [Conopco Inc. d/b/a Unilever]

Vaseline Lip Therapy Advanced Formula PDP and drug facts

B4 [Midway Advanced Products, LLC]

Drug Facts

PubMed Articles [16276 Associated PubMed Articles listed on BioPortfolio]

Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?

There are few randomized controlled studies to guide the treatment of advanced cutaneous squamous cell carcinoma. The existing treatments are mostly based on case reports and small case series. Here w...

Cell-Mediated Enzyme Prodrug Cancer Therapies.

Cell-directed gene therapy is a promising new frontier for the field of targeted cancer therapies. Here we discuss the current pre-clinical and clinical use of cell-mediated enzyme prodrug therapy (EP...

Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.

Chimeric antigen receptors (CARs) are synthetic receptors that reprogram T lymphocytes to target chosen antigens. The targeting of CD19, a cell surface molecule expressed in the vast majority of leuke...

Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice.

Nivolumab is an important new therapy option for patients with advanced renal cell carcinoma, and has a different mechanism of action compared with vascular endothelial growth factor -targeted therapi...

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.

Here we report a phase 1b clinical trial testing the impact of oncolytic virotherapy with talimogene laherparepvec on cytotoxic T cell infiltration and therapeutic efficacy of the anti-PD-1 antibody ...

Clinical Trials [12243 Associated Clinical Trials listed on BioPortfolio]

Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma

Previous rather poor results in liver transplantation (LT) of patients with advanced hepatocellular carcinoma (HCC) have made the application of LT very limited in treatment of HCC. The ad...

Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy

Evaluating the safety and efficacy of Lentiviral Hematopoietic Stem Cell Gene Therapy for advanced stage of Metachromatic Leukodystrophy and adrenoleukodystrophy.

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

This is a Phase 2 trial that will evaluate the safety and efficacy of PF-02341066 in patients with advanced non-small cell lung cancer with a specific gene profile involving the ALK gene. ...

Gene Therapy in Treating Patients With Advanced Bladder Cancer

RATIONALE: Inserting the p53 gene into a person's bladder cancer cells may improve the body's ability to fight cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy in...

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

This is multicenter, open-label, randomized, active-controled, phase IV study of local direct intra-tumor injection of rAd-p53 monotherapy, with concurrent radioactive iodine , or combinat...

Companies [2771 Associated Companies listed on BioPortfolio]

ADVANCED CELL & GENE THERAPY, LLC

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, ...

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is ...

Cell Genesys

Cell Genesys is a leader in the development and commercialization of innovative therapeutic products for cancer based on gene therapy technologies. The company has a broad portfolio of clinical stage...

RheoGene Inc

RheoGene is developing the RheoSwitch® Therapeutic System (RTS) for cell and gene therapy. RTS delivers therapeutic gene products in the patient to the right place, at the right time, and at the righ...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology re...

More Information about "ADVANCED CELL & GENE THERAPY, LLC" on BioPortfolio

We have published hundreds of ADVANCED CELL & GENE THERAPY, LLC news stories on BioPortfolio along with dozens of ADVANCED CELL & GENE THERAPY, LLC Clinical Trials and PubMed Articles about ADVANCED CELL & GENE THERAPY, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ADVANCED CELL & GENE THERAPY, LLC Companies in our database. You can also find out about relevant ADVANCED CELL & GENE THERAPY, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record